Tuesday, July 31, 2018

UPDATE 3-Genzyme rare disease drug sales drive Sanofi profit

* 2018 EPS growth now expected between 3 and 5 percent (Adds Dupixent figures, shares, comment)
https://ift.tt/2LRi7Z1 support@endlesssupplies.biz (Endless Supplies .Biz) July 31, 2018 at 04:02AM
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)